[DPHARMA] QoQ Cumulative Quarter Result on 31-Mar-2011 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Mar-2011 [#1]
Profit Trend
QoQ- -79.34%
YoY- 15.48%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Revenue 138,132 105,096 68,329 32,984 131,437 99,242 64,777 65.44%
PBT 34,728 26,892 17,166 7,875 35,408 26,802 16,582 63.47%
Tax -8,023 -6,515 -4,310 -1,951 -6,739 -6,747 -4,146 55.10%
NP 26,705 20,377 12,856 5,924 28,669 20,055 12,436 66.21%
-
NP to SH 26,705 20,377 12,856 5,924 28,669 20,055 12,436 66.21%
-
Tax Rate 23.10% 24.23% 25.11% 24.77% 19.03% 25.17% 25.00% -
Total Cost 111,427 84,719 55,473 27,060 102,768 79,187 52,341 65.26%
-
Net Worth 163,783 162,405 154,105 162,320 156,881 148,504 140,182 10.89%
Dividend
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Div 24,983 - 4,859 - 222 - 6,245 151.36%
Div Payout % 93.56% - 37.80% - 0.77% - 50.22% -
Equity
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Net Worth 163,783 162,405 154,105 162,320 156,881 148,504 140,182 10.89%
NOSH 138,799 138,807 138,833 138,735 138,832 138,788 138,794 0.00%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
NP Margin 19.33% 19.39% 18.81% 17.96% 21.81% 20.21% 19.20% -
ROE 16.31% 12.55% 8.34% 3.65% 18.27% 13.50% 8.87% -
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 99.52 75.71 49.22 23.77 94.67 71.51 46.67 65.44%
EPS 19.24 14.68 9.26 4.27 20.65 14.45 8.96 66.21%
DPS 18.00 0.00 3.50 0.00 0.16 0.00 4.50 151.34%
NAPS 1.18 1.17 1.11 1.17 1.13 1.07 1.01 10.89%
Adjusted Per Share Value based on latest NOSH - 138,735
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 14.36 10.93 7.10 3.43 13.66 10.32 6.73 65.51%
EPS 2.78 2.12 1.34 0.62 2.98 2.08 1.29 66.60%
DPS 2.60 0.00 0.51 0.00 0.02 0.00 0.65 151.34%
NAPS 0.1703 0.1688 0.1602 0.1687 0.1631 0.1544 0.1457 10.92%
Price Multiplier on Financial Quarter End Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 -
Price 2.02 2.10 2.34 2.35 2.39 2.44 2.45 -
P/RPS 2.03 2.77 4.75 9.88 2.52 3.41 5.25 -46.83%
P/EPS 10.50 14.31 25.27 55.04 11.57 16.89 27.34 -47.07%
EY 9.52 6.99 3.96 1.82 8.64 5.92 3.66 88.80%
DY 8.91 0.00 1.50 0.00 0.07 0.00 1.84 185.40%
P/NAPS 1.71 1.79 2.11 2.01 2.12 2.28 2.43 -20.83%
Price Multiplier on Announcement Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 22/02/12 21/11/11 18/08/11 25/05/11 23/02/11 26/11/10 24/08/10 -
Price 2.12 2.10 2.22 2.57 2.45 2.38 2.45 -
P/RPS 2.13 2.77 4.51 10.81 2.59 3.33 5.25 -45.10%
P/EPS 11.02 14.31 23.97 60.19 11.86 16.47 27.34 -45.34%
EY 9.08 6.99 4.17 1.66 8.43 6.07 3.66 82.95%
DY 8.49 0.00 1.58 0.00 0.07 0.00 1.84 176.38%
P/NAPS 1.80 1.79 2.00 2.20 2.17 2.22 2.43 -18.08%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment